ABSTRACT
I-iothalamate
clearance while simultaneously determining creatinine clearance.
Other Measurements

24-hour urinary albumin excretion.
Results
In 121 patients with ADPKD (56% men; mean age, 40 ± 11 [SD] years) and 215 controls (48% men; mean age, 53 ± 10 years), measured GFR (mGFR) was 78 ± 30 and 98 ± 17 mL/min/1.73 m 2 , respectively, and CCr(TS) was 15.9 ± 10.8 and 10.9 ± 10.6 mL/ min/1.73 m 2 , respectively (P < 0.001). The higher CCr(TS) in patients with ADPKD remained significant after adjustment for covariates and appeared to be dependent on mGFR. Correlation and accuracy between mGFR and CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) estimated GFR (eGFR) were 0.95 and 99%, respectively; between mGFR and MDRD (Modification of Diet in Renal Disease) Study eGFR, they were 0.93 and 97%, respectively. Values for bias, precision, and accuracy were similar or slightly better than in controls. In addition, change in mGFR during 3 years of follow-up in 45 patients with ADPKD correlated well with change in eGFR.
Limitations
Cross-sectional, single center.
Conclusions
CCr(TS) in patients with ADPKD is higher than that in controls, but this effect is limited and observed at only high-normal mGFR. Consequently, the CKD-EPI and MDRD Study equations perform relatively well in estimating GFR and change in GFR in patients with ADPKD.
INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and has a prevalence of approximately 1 in every 1,000 individuals. 1 It is characterized by progressive cyst formation in both kidneys and loss of kidney function. 1, 2 In ADPKD, cysts are formed through epithelial cell proliferation in renal tubules.
These proliferated cells are less well differentiated, 3, 4 which may alter tubular functioning. It has been suggested that at earlier stages of ADPKD, cysts are seen mainly in the proximal tubules and loops of Henle, and that during later stages, these cysts diminish and cysts in the collecting ducts dominate. 4 Normal tubular function includes degradation of proteins, reabsorption of water, secretion of waste products, and regulation of homeostatic function. Creatinine is secreted as waste product by proximal tubular cells. In healthy individuals, tubular secretion of creatinine (CCr[TS]) accounts for 10% -15% of total renal creatinine clearance (CCr). 5, 6 In patients with ADPKD, proliferation and dedifferentiation of proximal tubular cells may result in aberrant tubular creatinine secretion.
To our knowledge, analysis of CCr(TS) in patients with ADPKD has not been performed yet. Therefore, we investigated CCr(TS) in patients with ADPKD and compared this with the situation in healthy controls. If CCr(TS) is affected in ADPKD, it may be expected that glomerular filtration rate (GFR) estimating equations perform less well in patients with ADPKD. We therefore also investigated the performance of GFR estimating equations in this patient group cross-sectionally and longitudinally.
METHODS
Patient Population
For this study, all consecutive patients with ADPKD visiting our outpatient clinic from for analysis. These 2 groups did not differ in baseline characteristics listed in Table 1 .
Only a slight difference in use of antihypertensive medication was observed (13.3% and 20.6%; P < 0.001). None of the study participants used medication that could interact with CCr(TS), such as trimethoprim-sulfamethoxazole 8 or cimetidine 6 . This study was performed in adherence to the Declaration of Helsinki. All participants gave written informed consent.
Measurements and Calculations
All participants collected a 24-hour urine sample the day preceding the kidney function measurement. Urinary albumin concentration was determined in these samples by nephelometry (BNII; Dade Behring Diagnostics). At the day of kidney function measurement, blood pressure was assessed at rest in a supine position with an automatic device (Dinamap; GE Medical Systems) for 15 minutes during kidney function measurement, and weight and height were determined. Body mass index (BMI) was calculated as weight in kilograms divided by height in square meters.
Body surface area was calculated according to the DuBois formula. 9 Baseline blood samples were drawn for determination of creatinine. Abbreviations are: BP, blood pressure; mGFR, measured glomerular filtration rate; CCR(TS), tubular secretion of creatinine; UcrV creatinine excretion; GFcr, glomerular filtered load of creatinine, TScr tubular secretion of creatinine; ERPF, estimated renal plasma flow; NA, not applicable. Parametric variables are expressed as mean ± SD, whereas non-parametric variables are given as median (interquartile range). P-values indicate differences between whole study group and controls. P-values are calculated by Student's t-test when normally distributed and by Mann-Whitney U test when non-normally distributed. I-iothalamate as a measure of GFR for voiding errors. This procedure has been described in detail previously. 14 For calculating CCr, a similar procedure was followed. Urine was collected by spontaneous voiding. CCr and mGFR are given as the average of both 2-hour clearance periods and normalized for body surface area. Day-to-day variability in mGFR using this method is 2.5%. 13 CCr(TS) was defined as CCr minus mGFR. Urinary creatinine excretion, glomerular filtered load of creatinine, and CCr(TS) were calculated as described previously. 15 
Statistical Analysis
Analyses were performed with SPSS, version 18.0 (SPSS Inc). Normality was assessed by Q-Q plot. Normal distributed variables are expressed as mean ± standard deviation (SD), whereas non-normally distributed variables are given as median (interquartile range [IQR]). A 2-sided P < 0.05 was considered to indicate statistical significance.
Differences in baseline characteristics between patients with ADPKD and controls were tested using 2-sample t-test when normally distributed or Mann-Whitney test when not normally distributed. Follow-up data for patients with ADPKD were tested using paired-samples t test.
To investigate whether CCr(TS) differed between patients with ADPKD and controls, multivariate linear regression analysis was performed, adjusting for covariates that potentially may be confounders (mGFR, sex, BMI, urinary albumin excretion, and total kidney volume). Albuminuria and total kidney volume were natural log transformed to fulfil the requirement of normal distribution of residuals. Two models were built. First, a possible difference in CCr(TS) between patients with ADPKD and controls was assessed adjusting for mGFR only (model 1 
RESULTS
Study Participants
Patient characteristics are listed in Table 1 
Tubular Secretion of Creatinine
CCr(TS) was higher in patients with ADPKD than in controls (15.9 ± 10.8 vs 10.9 90 ± 10.6 mL/min/1.73m 2 ; difference P < 0.001). Table 2 shows 2 multiple regression models. Model 1 shows that CCr(TS) was higher in patients with ADPKD than controls when adjusted for mGFR. Model 2 shows that this difference remained significant when adjusted for covariates that are known from the literature to also potentially be associated with CCr(TS): age, sex, BMI, filtration fraction, serum albumin level, and albuminuria. In our model, higher BMI was associated significantly with increased CCr(TS). In contrast, albuminuria and filtration fraction showed no association with CCr(TS). The difference between patients with ADPKD and controls in CCr(TS) was found to be dependent on mGFR level because the interaction term with mGFR was found to be statistically significant (P = 0.003). In a sensitivity analysis, use of antihypertensive medication and different classes of antihypertensive medications were added to the multivariate model. Neither was associated with CCr(TS) (data not shown). It also shows that in patients with ADPKD, but not controls, mGFR is correlated with Given the fact that the association between mGFR and CCr(TS) was different between ADPKD patients and control subjects, we also investigated which factors may be associated with CCr(TS) in ADPKD and controls separately. In ADPKD patients, CCr(TS) was not associated with ln total kidney volume (β 0.3 CI -3.8;4.3, p=0.9), female sex (β -2.7 CI -7.1;1.7 p=0.2), filtration fraction (β -50.2, CI -115;14.6 p=0.1), serum albumin (β 0.1, CI -0.7;0.9 p=0.8) or ln albuminuria (β 0.01, CI -1.8;1.9 p=0.9).
However, BMI (β 0.8 CI 0.3;1.2 p=0.003) and baseline mGFR (β 0.1, CI 0.01; 0.2 p=0.03) were significantly associated with CCr(TS) , whereas age (β -0.7 CI -7.1; 1.7 p=0.07) showed a trend towards such an association. In controls, essentially similar findings were observed, with body mass index also being associated with CCr(TS) (β 0.9, CI 0.4;1.4 p<0.001). The only difference being that in healthy controls, in contrast to the situation in ADPKD patients, baseline mGFR was not associated with CCr(TS).
Performance of GFR Estimating Equations in ADPKD Patients
The correlation between mGFR and eGFR in patients with ADPKD using the CKD-EPI and MDRD Study equations, respectively, is shown in Figure 2 . A high correlation between mGFR and eGFR CKD-EPI and eGFR MDRD was observed (R = 0.95 [P < 0.001] and R = 0.93 [P < 0.001], respectively). Figure 3 shows Bland-Altman plots of mGFR versus the difference between mGFR and eGFR. eGFR CKD-EPI and Figure 1 . Tubular secretion of creatinine in ADPKD patients and controls stratified according to mGFR value (<60, 60-90, 90-105, 105-120 and >120 mL/min/1.73m 2 , resp.). Data are given as point estimates with standard error of the mean, calculated from the regression model (Table 2) , in which the ADPKD x mGFR interaction term was highly significant (p=0.003). P-values are obtained from the contrasts in the regression model and are given at the top of the figure. 
Performance of the CKD-EPI and MDRD Study equations to estimate GFR in patients
with ADPKD and controls is listed in Table 3 . In controls and patients with ADPKD, the CKD-EPI equation performs slightly better than the MDRD Study equation to estimate GFR with numerically less bias and better precision and accuracy. In patients with ADPKD, both eGFR equations underestimated true GFR slightly. The precision and accuracy of both GFR estimating equations hardly differed between patients with ADPKD and controls, with bias, precision, and accuracy even slightly better in patients with ADPKD.
Performance of GFR Estimating Equations to Measure Change in GFR
Follow-up data for mGFR were available for 45 of 121 patients with ADPKD. Three years after the baseline measurement, GFR had decreased in these participants from 82.1 ± 22.9 to 73.6 ± 29.1 mL/min/ 1.73m 2 (P < 0.001), and CCr(TS), from 15.9 ± 9.0 to 13.4 ± 7.8 mL/min/1. Figure 5 shows Bland-Altman plots of the change in mGFR versus the difference between change in mGFR and eGFR. There was homogeneity in the differences between changes in mGFR and eGFR for both GFR estimating equations. Bias is defined as mean difference between mGFR and eGFR. Precision is defined as one SD of the bias. Accuracy is defined as the percentage of eGFR values within 10% (P 10 ) and 30% (P 30 ) of their corresponding mGFR value. P-values are calculated by Student's t-test when normally and X 2 when non-normally distributed. Table 3 . Performance of CKD-EPI and MDRD equations to estimate absolute GFR at baseline. 
DISCUSSION
In this study, we investigated CCr(TS) in patients with ADPKD and controls and studied the consequences of a potential difference for the performance of GFR estimating equations. In patients with ADPKD with high-normal mGFR, we found higher CCr(TS) compared with healthy controls, whereas at low-normal mGFR, no significant difference was observed. Creatinine-based eGFR correlated well with mGFR in patients with ADPKD in cross-sectional and longitudinal analyses.
In line with the literature, our data show that in healthy participants, CCr(TS) accounts for 12% of total CCr. 6 We found CCr(TS) to be elevated in patients with ADPKD with higher kidney function compared with healthy controls with similar kidney function.
At lower kidney function, this difference between patients with ADPKD and controls was no longer observed. What can be the reason for this higher CCr(TS) in patients with ADPKD with well-preserved kidney function? Based on the literature, 5 different explanations may be possible.
First, it has been observed that CCr(TS) is increased in patients with nephroticrange proteinuria. 16 It was suggested that in such individuals, albumin reabsorption in the proximal tubule stimulates CCr(TS). 16 In the patients with ADPKD included in our study, albuminuria was only limited. Furthermore, no association was observed between albuminuria and CCr(TS) in controls or patients with ADPKD. Second, obese individuals have been found to have increased CCr(TS), the underlying mechanism has not been elucidated yet. 5 Consistent with this, we found a significant association between BMI and CCr(TS) in controls and patients with ADPKD. Importantly, there was no difference in BMI between controls and patients with ADPKD. Third, protein intake may influence CCr(TS). 17 However, no significant difference in 24-hour urea excretion was observed between controls and patients with ADPKD, indicating that protein intake was similar in both groups. Our observations therefore make differences in albuminuria, obesity, or protein intake between patients with ADPKD and controls unlikely as a cause for the increased CCr(TS) in patients with ADPKD. Fourth, glomerular hyperfiltration has been shown to be associated with increased proximal tubular activity in patients with diabetes, 18, 19 and consequently, proximal tubules may secrete more creatinine. In clinical practice, it is impossible to directly measure hyperfiltration. However, it is assumed that hyperfiltration is occurring in patients with ADPKD, even when kidney function is (near) normal and not different from that in age-and sex-matched controls. [20] [21] [22] In our study, we found a significant difference in filtration fraction between patients with ADPKD and controls, but no association between filtration fraction and CCr(TS) in either the overall group or patients with ADPKD or controls separately. These findings may suggest that hyperfiltration does not play a major role in causing the increased CCr(TS). However, our findings should be interpreted cautiously because high filtration fraction is only a surrogate for hyperfiltration. A fifth potential explanation for higher CCr(TS) in patients with ADPKD with well-preserved kidney function could be that the increased creatinine secretion is caused by increased surface of the proximal tubular cells as a result of sac-like protrusion of the tubular wall and/or dilated tubules in ADPKD. 4, 23, 24 Our observational data unfortunately do not allow a firm conclusion on the mechanism of the increased creatinine secretion in patients with ADPKD with near-normal kidney function.
Because CCr(TS) is increased in patients with ADPKD with (near) normal kidney function, this may influence the performance of GFR estimating equations. Upcoming therapeutic interventions in this patient group need to be investigated for efficacy with respect to kidney function preservation in large patient groups. [25] [26] [27] For this purpose, adequate GFR estimating equations are needed. We therefore investigated the association between mGFR and eGFR. In a cross-sectional analysis, we found that eGFR CKD-EPI and eGFR MDRD correlated well with mGFR. The values for bias, precision and accuracy that we found in our controls are consistent with values obtained in the validation cohort of the study in which the CKD-EPI equation was developed.
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Although patients with ADPKD at high-normal mGFR had increased CCr(TS), this apparently did not result in high bias or low precision or accuracy of the equations that use creatinine to estimate GFR. In patients with ADPKD, values for bias, precision, and accuracy were numerically even slightly better than in controls, although differences did not always reach statistical significance.
To date, only 2 other studies investigated the performance of GFR estimating equations in patients with ADPKD. 28, 29 We found slightly higher accuracy than Orskov Consequently, their results will be influenced less by random measurement variation, and true associations will become more apparent. Of note, the study by Rule et al, 30 as well as our study, had 3 years of follow-up. In both studies, a significant correlation was found between change in mGFR and change in eGFR. In contrast, the study that suggested that changes in GFR cannot be assessed using GFR estimating equations had only 1 year of follow-up. 28 What might be the consequences of our study? From the literature, it is known that kidney function in patients with ADPKD, as measured by creatinine or creatinine-based GFR estimates, remains relatively stable during a prolonged period and deteriorates more rapidly from a certain time onward. 31 Hyperfiltration of nephrons not affected by obstruction by (micro)cysts has been mentioned as a mechanism explaining this phenomenon. 20, 31 In the present study, we show that in patients with ADPKD, CCr(TS)
is increased significantly at higher mGFRs, thus contributing to a lower plasma A limitation of our study is that our results with respect to the correlation between mGFR and eGFR primarily hold true for a cross-sectional study design because follow-up data were available for only a limited number of participants. Furthermore, we did not include a non-ADPKD CKD control group. We observed higher creatinine secretion in patients with ADPKD compared with healthy controls in only the high mGFR range. Our healthy control group has a normal mGFR range and therefore is perfectly suited for our study. Such a high mGFR range probably will not be available in a non-ADPKD CKD cohort. Of note, in a previous study, CCr(TS) was found to be reduced in patients with ADPKD compared with other CKD groups. 32 As result, it cannot be concluded that increased CCr(TS) is specific for ADPKD. Third, a minor difference in the use of antihypertensive medication was observed between missing controls and controls. However, sensitivity analysis with antihypertensive medication added to the multivariate model did not change our results. Strengths of our study are that we measured GFR by a gold-standard technique (i.e. 125 I-iothalamate clearance) and simultaneously assessed CCr. This was done in a relatively large well-phenotyped cohort of 121 patients with ADPKD at various CKD stages, as well as in healthy controls.
In conclusion, our study shows that patients with ADPKD have higher CCr(TS), but only at high-normal GFR. At lower GFR, no difference is observed between patients with ADPKD and controls. This increased creatinine secretion has no major negative effect on GFR estimated with the CKD-EPI and MDRD Study equations.
These GFR estimating equations perform relatively well and therefore can be used in this patient group. 
